Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Recruiting1
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06541691Not ApplicableRecruiting
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
Atherosclerotic Cardiovascular DiseaseCarotid Artery StenosisCarotid Atherosclerosis+4 more
PrincipalinvestigatorStart date: 2024-03-06
NCT06261606Not ApplicableUnknown
Feasibility of a Multifaceted Program to Reduce Cardiovascular Complications of Air Pollution
AtherosclerosisCarotid Artery DiseasesCoronary Artery Disease+2 more
PrincipalinvestigatorStart date: 2024-01-28
NCT05705089Phase 3Completed
Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
Left Ventricular ThrombusST Segment Elevation Myocardial Infarction
PrincipalinvestigatorStart date: 2020-07-30
NCT05172115Phase 3Terminated
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
Embolism, PulmonaryPulmonary EmbolismPulmonary Thromboembolisms+1 more
PrincipalinvestigatorStart date: 2018-12-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

AtherosclerosisCarotid Artery DiseasesCoronary Artery Disease
Similarity Score6%

Ron Waksman, MD

Medstar Health Research Institute

Related
18 trials

Shared therapeutic areas:

Coronary Artery DiseaseMyocardial IschemiaST Elevation Myocardial Infarction
Similarity Score6%

Bon-Kwon Koo, MD, PhD

Seoul National University Hospital

Related
18 trials

Shared therapeutic areas:

Coronary Artery DiseaseST Elevation Myocardial InfarctionMyocardial Ischemia
Similarity Score6%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

Coronary Artery DiseasePeripheral Arterial Disease
Similarity Score4%

Joo Myung Lee, MD, MPH, PhD

Samsung Medical Center

Related
17 trials

Shared therapeutic areas:

Myocardial IschemiaCoronary Artery Disease
Similarity Score4%

Yundai Chen, M.D.

Chinese PLA General Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery DiseaseAtherosclerosis
Similarity Score4%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Pulmonary EmbolismAtherosclerotic Cardiovascular Disease

Worked with same sponsors:

Brigham and Women's Hospital
Similarity Score4%

Esmael M Ahmed, MD

Assistant Prof of Neurology

Related
16 trials

Shared therapeutic areas:

Ischemic StrokeCarotid Stenosis
Similarity Score4%

Anissa MEGZARI

Centre Hospitalier Universitaire de Nīmes

Related
29 trials

Shared therapeutic areas:

Carotid Stenosis
Similarity Score2%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06541691Not ApplicablePrincipalInvestigator

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

Atherosclerotic Cardiovascular DiseaseCarotid Artery StenosisCarotid Atherosclerosis+4 more
Recruiting
NCT06261606Not ApplicablePrincipalInvestigator

Feasibility of a Multifaceted Program to Reduce Cardiovascular Complications of Air Pollution

AtherosclerosisCarotid Artery DiseasesCoronary Artery Disease+2 more
Unknown
NCT05705089Phase 3PrincipalInvestigator

Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI

Left Ventricular ThrombusST Segment Elevation Myocardial Infarction
Completed
NCT05172115Phase 3PrincipalInvestigator

Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE

Embolism, PulmonaryPulmonary EmbolismPulmonary Thromboembolisms+1 more
Terminated

All 4 trials loaded